Related Experiment Video

Updated: Aug 11, 2026

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Interpretation of the breast screening trials: a commentary on the recent paper by Gøtzsche and Olsen

S W Duffy1

  • 1Department of Mathematics, Statistics and Epidemiology, Imperial Cancer Research Fund, Lincoln's Inn Fields, London, UK. s.duffy@icrf.icnet.uk

Breast (Edinburgh, Scotland)
|February 18, 2004
PubMed

Abstract:

This paper reviews and rebutts the recent criticisms of breast screening trials published earlier this year in the Lancet.

More Related Videos

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
06:07

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

Published on: June 7, 2020

Related Experiment Videos

Last Updated: Aug 11, 2026

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
09:29

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay
06:07

Screening for Phytoestrogens using a Cell-based Estrogen Receptor β Reporter Assay

Published on: June 7, 2020

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Articles linked to this work by shared authors, journal, and citation graph.

First results from five multidisciplinary diagnostic centre (MDC) projects for non-specific but concerning symptoms, possibly indicative of cancer.

British journal of cancer·2020

Impact of choice of volumetry software and nodule management guidelines on recall rates in lung cancer screening.

European journal of radiology·2019

Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer.

Breast (Edinburgh, Scotland)·2019

The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.

BMC cancer·2018

CT screening for lung cancer: Is the evidence strong enough?

Lung cancer (Amsterdam, Netherlands)·2015

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening.

Thorax·2015

Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive breast cancer in the Brazilian public healthcare system.

Breast (Edinburgh, Scotland)·2026

Effect of dose-dense adjuvant chemotherapy in patients with node-positive early breast cancer according to estrogen receptor levels: an exploratory analysis of the GIM2 trial.

Breast (Edinburgh, Scotland)·2026

Subtype-specific screen-detected and interval breast cancer rates in population screening: a BreastScreen Queensland cohort study.

Breast (Edinburgh, Scotland)·2026

Risk factors of immune-related adverse events in patients with early-stage breast cancer: Findings from a multi-institutional retrospective study.

Breast (Edinburgh, Scotland)·2026

Tucatinib, trastuzumab, and capecitabine as second- or third-line therapy after trastuzumab deruxtecan in HER2-positive metastatic breast cancer: A multicenter retrospective study in France.

Breast (Edinburgh, Scotland)·2026

Analysis of outcomes of nab-paclitaxel compared to other taxanes in early breast cancer: A study revealing the critical role of calendar-time bias in real-world drug comparisons.

Breast (Edinburgh, Scotland)·2026

Multidimensional Positive Body Image and Clinical Change During Eating Disorder Treatment: Preliminary Longitudinal Findings.

The International journal of eating disorders·2026

Implementing Person-Centered Dementia Care Practices Using a Care Community Coaching Intervention.

The Gerontologist·2026

EVIDENCE-BASED PHARMACOTHERAPY FOR ANXIETY DISORDERS COMORBID WITH PTSD: A SYSTEMATIC REVIEW.

Georgian medical news·2026

Relationship between hypochondriasis and clinical self-efficacy in nursing students: A cross-sectional multi-institutional study.

Journal of education and health promotion·2026

Psychological vulnerability and opioid medication use disorder risk in chronic pain: the mediating role of affective states and gender differences.

Frontiers in public health·2026

Sudden Gains in Cognitive-Behavioral Therapy for Seasonal Affective Disorder.

Cognitive therapy and research·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us